Factors associated with complete remission after rituximab therapy for pemphigus
CJ Kushner, S Wang, N Tovanabutra, DE Tsai… - JAMA …, 2019 - jamanetwork.com
Importance Rituximab has emerged as a front-line therapy for pemphigus, but prognostic
factors for achieving complete remission off therapy (CROT) with oral systemic agents
remain unknown. Objectives To describe rates of CROT and relapse and identify prognostic
factors for achieving CROT after rituximab therapy for pemphigus. Design, Setting, and
Participants A single-center, retrospective, cohort study was conducted at the University of
Pennsylvania including 112 patients with pemphigus treated with rituximab with at least 12 …
factors for achieving complete remission off therapy (CROT) with oral systemic agents
remain unknown. Objectives To describe rates of CROT and relapse and identify prognostic
factors for achieving CROT after rituximab therapy for pemphigus. Design, Setting, and
Participants A single-center, retrospective, cohort study was conducted at the University of
Pennsylvania including 112 patients with pemphigus treated with rituximab with at least 12 …